Outbound Investment

New CSRC rules on overseas listing; China raises concerns over Ford gaining access to Chinese electric battery technology; and CSRC clarifies that it will not impose a blanket ban on mainland investors trading overseas stocks

The new listing rules, which give the Chinese securities regulator the ultimate power to oversee and block potential listings of Chinese companies on foreign bourses, may have wider implications, lawyers say.

China's IPO reform expands the registration-based system to main boards; Australian court refuses to deny Chinese arbitral award on public policy grounds; and China allows 12 market makers in the bond market to boost liquidity.

2022 regulatory trends in China, including data protection, TMT, capital markets, PE/VC, IP, dispute resolution, healthcare, banking & finance, sanctions and antitrust.

Charles Wu and Zaiguang Lu of Han Kun Law Offices review the significant legislative developments of 2022 affecting China's private equity and venture capital industry, and offer insights into the key trends, challenges and opportunities in the sector

Nathan Bush, Nicholas Klein, Catherine Pawluch, and Alexandra Kamerling of DLA Piper survey the risks under the Foreign Direct Investment regimes of key jurisdictions, starting with the U.S., Canada, and the U.K. in this two-part series

After a busy year on the capital markets, Haiping Li and Paloma Wang of Skadden Arps Slate Meagher & Flom LLP take a look at 2022's developments and what the next 12 months may hold.

U.S. gains full access to audits of Chinese companies; Fidelity targets China's mutual fund industry following the opening up of China's private pension industry; and China connects with Germany for overseas listings.

FDI screening has gone from "a niche area for defense industry deals where it might be relevant" to "a part of every deal structure, timetable, and assessment of regulatory risks," a competition partner in Brussels said.